BusinessPhoto: Business StandardDr Lal PathLabs Q2 Net Profit Rises 27.5% to ₹194 Crore
Dr Lal PathLabs reported a 27.5% year-on-year increase in consolidated net profit to ₹194 crore for Q2 FY27, up from ₹152 crore last year. Revenue rose 19.6% to ₹874 crore, driven by a 13.6% growth in sample volumes to 28.8 million and a 9% increase in patient coverage to 9 million. EBITDA grew 25% to ₹280 crore, with margin improving to 32.1%. CEO Shankha Banerjee highlighted rising demand for specialized testing.
Business Standard··Delhi




